Regulation of NKT cells by Ly49: Analysis of primary NKT cells and generation of NKT cell line

被引:53
作者
Maeda, M
Lohwasser, S
Yamamura, T
Takei, F
机构
[1] British Columbia Canc Res Ctr, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
[2] Natl Inst Neurosci, Dept Immunol, Kodaira, Tokyo, Japan
[3] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada
关键词
D O I
10.4049/jimmunol.167.8.4180
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
TCR alpha beta (+)NK1.1(+) (NKT) cells are known to express various NK cell-associated molecules including the Ly49 family of receptors for MHC class I, but its functional significance has been unclear. Here, we examined the expression of Ly49A, C/I and G2 on various NKT cell populations from normal and MHC class I-deficient C57BL/6 mice as well as their responsiveness to a-galactosylceramide (alpha -GalCer), a potent stimulator of CD1d-restricted NKT cells. The frequency and the level of Ly49 expression varied among NKT cells from different tissues, and were regulated by the expression of MHC class I and CD1d in the host. Stimulation of various NKT cells with a-GalCer suggested that Ly49 expression inversely correlates with the responsiveness of NKT cells to alpha -GalCer. Moreover, alpha -GalCer presented by normal dendritic cells stimulated purified Ly49(-), but not Ly49(+), splenic NKT cells, whereas MHC class I-deficient dendritic cells presented alpha -GalCer to both LY49(+) and Ly49- NKT cells equally well. Therefore, MHC class I on APCs seems to inhibit activation of NKT cells expressing Ly49. To further characterize CD1d-restricted NKT cells, we generated an alpha -GalCer-responsive NKT cell line from thymocytes. The line could only be generated from LY49(-)NK1.1(+)CD4(+) thymocytes but not from other NKT cell subsets, and it lost expression of NK1.1 and CD4 during culture. Together, these results indicate the functional significance of Ly49 expression on NKT cells.
引用
收藏
页码:4180 / 4186
页数:7
相关论文
共 43 条
[31]   Stringent V beta requirement for the development of NK1.1(+) T cell receptor-alpha/beta(+) cells in mouse liver [J].
Ohteki, T ;
MacDonald, HR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :1277-1282
[32]  
Ortaldo JR, 1998, J IMMUNOL, V160, P1158
[33]   Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 NK T cells [J].
Pál, E ;
Tabira, T ;
Kawano, T ;
Taniguchi, M ;
Miyake, S ;
Yamamura, T .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :662-668
[34]   Liver CD4-CD8- NK1.1+ TCRαβ intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro [J].
Pied, S ;
Roland, J ;
Louise, A ;
Voegtle, D ;
Soulard, V ;
Mazier, D ;
Cazenave, PA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (03) :1463-1469
[35]  
SchartonKersten TM, 1996, J IMMUNOL, V157, P4045
[36]   CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells [J].
Schofield, L ;
McConville, MJ ;
Hansen, D ;
Campbell, AS ;
Fraser-Reid, B ;
Grusby, MJ ;
Tachado, SD .
SCIENCE, 1999, 283 (5399) :225-229
[37]  
Sköld M, 2000, EUR J IMMUNOL, V30, P2488, DOI 10.1002/1521-4141(200009)30:9<2488::AID-IMMU2488>3.0.CO
[38]  
2-F
[39]   The Ly-49 family: Genes, proteins and recognition of class I MHC [J].
Takei, F .
IMMUNOLOGICAL REVIEWS, 1997, 155 :67-77
[40]   Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1b [J].
Vance, RE ;
Kraft, JR ;
Altman, JD ;
Jensen, PE ;
Raulet, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) :1841-1848